UK politics
fromwww.theguardian.com
4 hours agoWho benefits if NHS drug prices soar? Donald Trump and big pharma. Just one more way he's menacing Britain | Polly Toynbee
US tariff threats and pricing demands are pushing UK pharmaceutical investment away, undermining British life sciences and straining NHS drug-price negotiations.